# Cipla Limited, Bengaluru, India – FDA Inspections

Source: https://www.keypedia.com/companies/cipla-limited/cefc1473-6852-4af7-b996-0730dc0834bb

> Inspection records and compliance data for Cipla Limited in Bengaluru. 7 FDA inspections on record, 2 Form 483s, last inspected November 13, 2024.

---

## Details

- Name: Cipla Limited
- FEI Number: 3002806691
- Facility Type: API Manufacturer
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING
- Address Line 1: Old Madras Road
- City: Bengaluru
- Country Name: India
- Address: Old Madras Road, Bengaluru, India
- Country: India

## Related Documents

- [483 - Cipla Limited - 2024-11-13](https://www.keypedia.com/records/483/cipla-limited/53061bbf-ca16-42ce-b780-25e91280d57b) — source: FDA, date: November 13, 2024
- [FDA Inspection 1254500 - Cipla Limited - 2024-11-13](https://www.keypedia.com/records/fda_inspections/cipla-limited/951ba987-ff08-4cf0-a68e-c3e82cccd492) — source: FDA, date: November 13, 2024
- FDA Inspection 1254500 - Cipla Limited - 2024-11-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 13, 2024
- FDA Inspection 1160347 - Cipla Limited - 2020-01-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2020
- [483 - Cipla Limited - 2019-07-19](https://www.keypedia.com/records/483/cipla-limited/3f8bbc67-313f-4442-bdc2-7deda4dfa0a7) — source: FDA, date: July 19, 2019
- [FDA Inspection 1099619 - Cipla Limited - 2019-07-19](https://www.keypedia.com/records/fda_inspections/cipla-limited/87069a20-8238-4cd8-bfc5-d14eaee4db66) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2019
- FDA Inspection 1009388 - Cipla Limited - 2017-04-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 5, 2017
- FDA Inspection 891868 - Cipla Limited - 2014-07-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 25, 2014
- FDA Inspection 790473 - Cipla Limited - 2012-06-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 28, 2012
- FDA Inspection 577409 - Cipla Limited - 2009-04-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 9, 2009

## Related Companies

- [Apitoria Pharma Private Limited](https://www.keypedia.com/companies/apitoria-pharma-private-limited/7797eab5-3d0a-4af9-a8ca-d75b2b0085f6)
- [Biocon Limited](https://www.keypedia.com/companies/biocon-limited/04ec7dc3-2fba-4501-9085-f0ef56c74bf5)
- [MSN Pharmachem Private Limited](https://www.keypedia.com/companies/msn-pharmachem-private-limited/4fdfe142-fe56-4555-a5bc-8abd429d8e25)
- [Teva API India Ltd- Malanpur](https://www.keypedia.com/companies/teva-api-india-ltd-malanpur/3a0b73ee-8e64-412f-9050-71e089560b19)
- [Laurus Labs Limited](https://www.keypedia.com/companies/laurus-labs-limited/adbb794f-9809-4e17-8519-aa385e27c8e1)
- [Apotex Pharmachem India Pvt Ltd.](https://www.keypedia.com/companies/apotex-pharmachem-india-pvt-ltd/8aa6fc29-dc9f-4154-90af-d0bf193414c5)
- [Sun Pharmaceutical Industries Limited- Madhuranthagam](https://www.keypedia.com/companies/sun-pharmaceutical-industries-limited-madhuranthagam/29c2adf0-d756-44f5-aefc-28f06be9616a)
- [Amphastar Nanjing Pharmaceuticals Inc](https://www.keypedia.com/companies/amphastar-nanjing-pharmaceuticals-inc/ad29710e-4137-4608-933e-8292394dcbc7)
- [MRIGlobal](https://www.keypedia.com/companies/mriglobal/52b432ff-e4bd-4ce2-80b5-30d4f35e5015)
- [DSM Nutritional Products France SAS](https://www.keypedia.com/companies/dsm-nutritional-products-france-sas/eded103b-8b4a-4634-a232-fb06e26f585d)

## Related Officers

- [Ralph H. Vocque](https://www.keypedia.com/people/ralph-h-vocque/dfd4e4f2-b03d-44ec-9dd7-7edcee303356)
- [Christopher S. Keating](https://www.keypedia.com/people/christopher-s-keating/94fcfd32-feb5-4b6c-80da-16202f4be01d)
- [Investigator](https://www.keypedia.com/people/kellia-n-hicks/44104c4a-70c1-47fc-9a77-c09c41bacc2b)
- [Investigator](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)